Apixaban (Eliquis) vs Warfarin Based on INR ControlApixaban (Eliquis) vs Warfarin Based on INR Control

The reduction in the primary efficacy end point of stroke or systemic embolism with apixaban was observed across a broad range of INR control in the warfarin-treated patients. Heartwire
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Cardiology News Source Type: news